Cellares unveils its first cGMP-compliant Cell Shuttle™ for cell therapy manufacturing.

Cellares, an IDMO focused on cell therapy manufacturing, unveils its first Current Good Manufacturing Practice (cGMP)-compliant Cell Shuttle™. This platform is designed to meet global patient demand while reducing costs and process failure rates. The cGMP Cell Shuttle will be used to manufacture cell therapies for first clinical trials, marking a key milestone in ensuring clinical readiness by the end of 2024.